Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 Fatty Acids for Oxidative Stress in HIV Patients
NCT02041520Phase 3Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Jan 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omega-3 fatty acid in oxidative stress, sponsored by Coordinación de Investigación en Salud. Primary endpoint: Malondialdehyde at 6 months. Started Jan 2013; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
oxidative stress
Beyond the preview
Go deeper on NCT02041520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02041520.